299 related articles for article (PubMed ID: 22456865)
1. Longitudinal trajectories of HbA1c and fasting plasma glucose levels during the development of type 2 diabetes: the Toranomon Hospital Health Management Center Study 7 (TOPICS 7).
Heianza Y; Arase Y; Fujihara K; Hsieh SD; Saito K; Tsuji H; Kodama S; Yahagi N; Shimano H; Yamada N; Hara S; Sone H
Diabetes Care; 2012 May; 35(5):1050-2. PubMed ID: 22456865
[TBL] [Abstract][Full Text] [Related]
2. Screening for pre-diabetes to predict future diabetes using various cut-off points for HbA(1c) and impaired fasting glucose: the Toranomon Hospital Health Management Center Study 4 (TOPICS 4).
Heianza Y; Arase Y; Fujihara K; Tsuji H; Saito K; Hsieh SD; Kodama S; Shimano H; Yamada N; Hara S; Sone H
Diabet Med; 2012 Sep; 29(9):e279-85. PubMed ID: 22510023
[TBL] [Abstract][Full Text] [Related]
3. Development of a new scoring system for predicting the 5 year incidence of type 2 diabetes in Japan: the Toranomon Hospital Health Management Center Study 6 (TOPICS 6).
Heianza Y; Arase Y; Hsieh SD; Saito K; Tsuji H; Kodama S; Tanaka S; Ohashi Y; Shimano H; Yamada N; Hara S; Sone H
Diabetologia; 2012 Dec; 55(12):3213-23. PubMed ID: 22955996
[TBL] [Abstract][Full Text] [Related]
4. Effect of HbA1c combined FPG on screening diabetes in health check-up.
Li LJ; Zhou JX; Chen HT; Song YL; Xue YM
Asian Pac J Trop Med; 2012 Jun; 5(6):472-5. PubMed ID: 22575981
[TBL] [Abstract][Full Text] [Related]
5. HbA1c 5·7-6·4% and impaired fasting plasma glucose for diagnosis of prediabetes and risk of progression to diabetes in Japan (TOPICS 3): a longitudinal cohort study.
Heianza Y; Hara S; Arase Y; Saito K; Fujiwara K; Tsuji H; Kodama S; Hsieh SD; Mori Y; Shimano H; Yamada N; Kosaka K; Sone H
Lancet; 2011 Jul; 378(9786):147-55. PubMed ID: 21705064
[TBL] [Abstract][Full Text] [Related]
6. Fasting plasma glucose and HbA1c as risk factors for Type 2 diabetes.
Inoue K; Matsumoto M; Akimoto K
Diabet Med; 2008 Oct; 25(10):1157-63. PubMed ID: 19046193
[TBL] [Abstract][Full Text] [Related]
7. Patient-directed titration for achieving glycaemic goals using a once-daily basal insulin analogue: an assessment of two different fasting plasma glucose targets - the TITRATE study.
Blonde L; Merilainen M; Karwe V; Raskin P;
Diabetes Obes Metab; 2009 Jun; 11(6):623-31. PubMed ID: 19515182
[TBL] [Abstract][Full Text] [Related]
8. Recent population changes in HbA(1c) and fasting insulin concentrations among US adults with preserved glucose homeostasis.
Cheng YJ; Kahn HS; Gregg EW; Imperatore G; Geiss LS
Diabetologia; 2010 Sep; 53(9):1890-3. PubMed ID: 20517591
[TBL] [Abstract][Full Text] [Related]
9. High normal HbA(1c) levels were associated with impaired insulin secretion without escalating insulin resistance in Japanese individuals: the Toranomon Hospital Health Management Center Study 8 (TOPICS 8).
Heianza Y; Arase Y; Fujihara K; Tsuji H; Saito K; Hsieh SD; Kodama S; Shimano H; Yamada N; Hara S; Sone H
Diabet Med; 2012 Oct; 29(10):1285-90. PubMed ID: 22486679
[TBL] [Abstract][Full Text] [Related]
10. Cut-off values of fasting and post-load plasma glucose and HbA1c for predicting Type 2 diabetes in community-dwelling Japanese subjects: the Hisayama Study.
Mukai N; Doi Y; Ninomiya T; Hata J; Hirakawa Y; Fukuhara M; Iwase M; Kiyohara Y
Diabet Med; 2012 Jan; 29(1):99-106. PubMed ID: 21726278
[TBL] [Abstract][Full Text] [Related]
11. Fasting plasma glucose 6-12 weeks after starting insulin glargine predicts likelihood of treatment success: a pooled analysis.
Karl D; Zhou R; Vlajnic A; Riddle M
Diabet Med; 2012 Jul; 29(7):933-6. PubMed ID: 22413808
[TBL] [Abstract][Full Text] [Related]
12. Low lung function and risk of type 2 diabetes in Japanese men: the Toranomon Hospital Health Management Center Study 9 (TOPICS 9).
Heianza Y; Arase Y; Tsuji H; Saito K; Amakawa K; Hsieh SD; Kodama S; Shimano H; Yamada N; Hara S; Sone H
Mayo Clin Proc; 2012 Sep; 87(9):853-61. PubMed ID: 22958989
[TBL] [Abstract][Full Text] [Related]
13. Haemoglobin A1c cut-off point to identify a high risk group of future diabetes: results from the Omiya MA Cohort Study.
Kato M; Noda M; Suga H; Nakamura T; Matsumoto M; Kanazawa Y;
Diabet Med; 2012 Jul; 29(7):905-10. PubMed ID: 22248349
[TBL] [Abstract][Full Text] [Related]
14. Macrovascular risk and diagnostic criteria for type 2 diabetes: implications for the use of FPG and HbA(1c) for cost-effective screening.
Jesudason DR; Dunstan K; Leong D; Wittert GA
Diabetes Care; 2003 Feb; 26(2):485-90. PubMed ID: 12547886
[TBL] [Abstract][Full Text] [Related]
15. A simple way to estimate mean plasma glucose and to identify Type 2 diabetic subjects with poor glycaemic control when a standardized HbA1c assay is not available.
Ozmen S; Cil T; Atay AE; Tuzcu AK; Bahceci M
Diabet Med; 2006 Oct; 23(10):1151-4. PubMed ID: 16978383
[TBL] [Abstract][Full Text] [Related]
16. Comparing incident diabetes as defined by fasting plasma glucose or by HbA(1c). The AusDiab, Inter99 and DESIR studies.
Soulimane S; Simon D; Shaw JE; Zimmet PZ; Vol S; Vistisen D; Magliano DJ; Borch-Johnsen K; Balkau B
Diabet Med; 2011 Nov; 28(11):1311-8. PubMed ID: 21824186
[TBL] [Abstract][Full Text] [Related]
17. A retrospective analysis of the fasting plasma glucose and glycosylated hemoglobin and pharmacotherapy change patterns among type 2 diabetes mellitus patients.
Davidson J; Koro C; Arondekar B; Lee BH; Fedder D
Clin Ther; 2008 Feb; 30(2):287-93. PubMed ID: 18343267
[TBL] [Abstract][Full Text] [Related]
18. Prognostic value of haemoglobin A1c and fasting plasma glucose for incident diabetes and implications for screening.
Schöttker B; Raum E; Rothenbacher D; Müller H; Brenner H
Eur J Epidemiol; 2011 Oct; 26(10):779-87. PubMed ID: 21947790
[TBL] [Abstract][Full Text] [Related]
19. Fasting plasma glucose and hemoglobin A1c in identifying and predicting diabetes: the strong heart study.
Wang W; Lee ET; Howard BV; Fabsitz RR; Devereux RB; Welty TK
Diabetes Care; 2011 Feb; 34(2):363-8. PubMed ID: 21270194
[TBL] [Abstract][Full Text] [Related]
20. HbA(1c) in adults without known diabetes from southern Europe. Impact of the new diagnostic criteria in clinical practice.
Bernal-Lopez MR; Santamaría-Fernandez S; Lopez-Carmona D; Tinahones FJ; Mancera-Romero J; Peña-Jimenez D; Jansen-Chaparro S; Baca-Osorio AJ; Cuesta-Muñoz AL; Serrano-Rios M; Gomez-Huelgas R
Diabet Med; 2011 Nov; 28(11):1319-22. PubMed ID: 21966956
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
